Literature DB >> 1012341

Effect of veratridine on the fluxes of 3H-noradrenaline and 3h-bretylium in the rat vas deferens in vitro.

S B Ross, D Kelder.   

Abstract

The effect of the depolarizing agent veratridine on the accumulation and release of of 3H-noradrenaline and 3H-bretylium in in the rat vas deferens in vitro was examined. Veratridine produced inhibition of the accumulation and induced marked release of the amines. In vas deferens from non-reserpinized rats the release of noradrenaline evoked by veratridine was partially antagonized by omission of Ca2+ in the incubation medium and partially inhibited by low concentrations of desipramine. In reserpinized vas deferens the release of noradrenaline like that of bretylium in normal vas was not affected by omission of Ca2+ but inhibited by low concentrations (3-5 X 10(-7) M) of desipramine. Tetrodotoxin and the local anesthetics millicaine and lidocaine antagonized the effect of veratridine on the accumulation and release of the amines, probably due to prevention of the depolarization. High concentration (3 X 10(-5) M) of desipramine had a similar effect on the release of noradrenaline in normal tissue in presence of external Ca2+. It is concluded that noradrenaline is released by veratridine from normal vas deferens by two mechanisms: 1) an exocytosis release, 2) a carrier mediated desipramine sensitive outward transport; In reserpinized tissue the second mechanism is solely responsible for the release of noradrenaline. Bretylium is only released by the second mechanism. It is suggested that the inhibiton of the amine accumulation by veratridine is due to an equilibrium of the influx at a low tissue to medium ratio.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1012341     DOI: 10.1007/bf00505085

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  13 in total

1.  On the mechanism of the accumulation of 3H-bretylium in peripheral sympathetic nerves.

Authors:  S B Ross; T Gosztonyi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  ON THE ROLE OF THE LIVER CATECHOL-O-METHYL TRANSFERASE IN THE METABOLISM OF CIRCULATING CATECHOLAMINES.

Authors:  A CARLSSON; B WALDECK
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1963

3.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

4.  On the mechanism of release of norepinephrine from sympathetic nerves induced by depolarizing agents and sympathomimetic drugs.

Authors:  N B Thoa; G F Wooten; J Axelrod; I J Kopin
Journal:  Mol Pharmacol       Date:  1975-01       Impact factor: 4.436

5.  Active transport of 3H-bretylium in the rat vas deferens in vitro.

Authors:  S B Ross; D Kelder
Journal:  Acta Physiol Scand       Date:  1976-06

6.  The effect of nerve stimulation on the uptake of noradrenaline into the adrenergic nerve terminals.

Authors:  J Häggendal; T Malmfors
Journal:  Acta Physiol Scand       Date:  1969 Jan-Feb

Review 7.  Coupled transport of sodium and organic solutes.

Authors:  S G Schultz; P F Curran
Journal:  Physiol Rev       Date:  1970-10       Impact factor: 37.312

8.  Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.

Authors:  K H Graffe; F J Stefano; S Z Langer
Journal:  Biochem Pharmacol       Date:  1973-05-15       Impact factor: 5.858

9.  Stimulation of serotonin N-acetyltransferase in pineal organ culture by drugs.

Authors:  R W Holz; T Deguchi; J Axelrod
Journal:  J Neurochem       Date:  1974-02       Impact factor: 5.372

10.  Mechanism of efflux of noradrenaline from adrenergic nerves in rabbit atria.

Authors:  D M Paton
Journal:  Br J Pharmacol       Date:  1973-12       Impact factor: 8.739

View more
  9 in total

1.  Uptake of 14C-tyramine and release of extravesicular 3H-noradrenaline in isolated perfused rabbit hearts.

Authors:  H Bönisch; E Rodrigues-Pereira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-07       Impact factor: 3.000

2.  Neuropeptide Y differentiates between exocytotic and nonexocytotic noradrenaline release in guinea-pig heart.

Authors:  M Haass; M Hock; G Richardt; A Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

3.  Nonexocytotic noradrenaline release induced by pharmacological agents or anoxia in human cardiac tissue.

Authors:  T Kurz; G Richardt; M Seyfarth; A Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-06       Impact factor: 3.000

4.  Tetrodotoxin-sensitive and -resistant effects of veratridine on the noradrenergic neurone of the rat vas deferens.

Authors:  H Bönisch; K H Graefe; B Keller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-12       Impact factor: 3.000

5.  Multiple effects of cocaine upon evoked secretion in bovine adrenal medullary chromaffin cells. Additional insight into the mechanism of action of cardiac glycosides.

Authors:  D A Powis; K J O'Brien; T L Török
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-03       Impact factor: 3.000

6.  Cardiac glycosides, calcium and the release of neurotransmitter from peripheral noradrenergic nerves.

Authors:  C M Tan; D A Powis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-03       Impact factor: 3.000

7.  Sodium-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.

Authors:  C J Zeitner; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-12       Impact factor: 3.000

8.  Sodium-dependence of the saturability of carrier-mediated noradrenaline efflux from noradrenergic neurones in the rat vas deferens.

Authors:  H Bönisch; G Fuchs; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

9.  Augmentation of the indirect sympathomimetic action of tyramine by cardioactive steroids is a consequence of elevated intracellular sodium.

Authors:  D A Powis; G M Madsen; T L Török
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-03       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.